Skip to main content
Equibles

Derek Archila

Analyst

Wells Fargo

Equibles does not estimate personal net worth.

About Derek Archila

Derek Archila is recorded as Analyst at Wells Fargo. Derek Archila has spoken on 12 earnings calls and 16 other investor events across 22 companies, most recently for Rhythm Pharmaceuticals, Inc. on November 3, 2026. Those appearances were for Rhythm Pharmaceuticals, Inc. (RYTM), Argenx SE (ARGX), Incyte Corp (INCY), BridgeBio Pharma, Inc. (BBIO), C4 Therapeutics, Inc. (CCCC) and 17 other companies. The companies whose calls Derek Archila spoke on are classified in the Healthcare sector.

Derek Archila on recent calls

“So just on the reimbursed patients, it seems like they increased 20% quarter over quarter. It does seem access has improved materially with two-thirds of patients essentially getting reimbursed or paid for by 60 days.”
Analyst — Wells Fargo, Rhythm Pharmaceuticals Q3 2026 Earnings Conference Call ·
“Maybe just staying on the limb girdle theme here, as we think about the limb girdle launch, how should we be thinking about modeling these first couple quarters?”
Analyst — Wells Fargo, BridgeBio Q3 Earnings Call ·
“I was just wondering if you could provide some color on how both MG and CIDP revenues are growing. Is it about the same rate, quarter over quarter?”
Analyst — Wells Fargo, Third Quarter 2026 Financial Results and Business Update ·
“I'm one of the senior biotech analysts here at Wells. Very excited to have C4 Therapeutics team up here with us. From the team, we have Andy Hirsch, President and CEO, Scott Boyle, Chief Business Officer, as well as Kendra Adams, Chief Financial Officer.”
Analyst — Wells Fargo, 2026 Wells Fargo Healthcare Conference ·
“All right, everyone, I think we'll get started here with the next fireside discussion. My name is Derek Archilla. I'm one of the senior biotech analysts here at Wells.”
Analyst — Wells Fargo, Wells Fargo 21st Annual Healthcare Conference ·

Affiliation history

  • Wells Fargo

    Analyst

    Source not stated

    Current

Company network

Soleno Therapeutics Inc

Biotechnology · Healthcare

1 appearance Latest appearance 2026-02-25

Apellis Pharmaceuticals, Inc.

Biotechnology · Healthcare

1 appearance Latest appearance 2026-01-12

Recent activity

Show 16 earlier activities